In conclusion, our findings demonstrated that the number of Gal-3 positive cells associated with tissue damage in different ways suggests a dual role of this protein in the pathogenesis of pediatric NAFLD, even if the role of Gal-3 deserves further studies that could help plan future studies of pharmacological targeting of this molecule. Here, LGALS3 is linked to metabolic dysfunction-associated steatotic liver disease.